High Variability of Peptidylarginine Deiminase 4 (PADI4) in a Healthy White Population: Characterization of Six New Variants of PADI4 Exons 2-4 by a Novel Haplotype-specific Sequencing-based Approach
Overview
Authors
Affiliations
Seven single nucleotide polymorphisms (SNPs) of the peptidylarginine deiminase 4 (PADI4) gene have recently been reported to be strongly associated with rheumatoid arthritis in Japanese individuals. These SNPs are located in or close to exons 2-4 of PADI4 and are organized in at least four different haplotypes. However, a detailed sequencing-based characterization of the PADI4 gene in other populations is still lacking. We therefore analyzed exons 2-4 of the PADI4 gene in 102 healthy white Germans individuals by DNA sequencing and characterized new variants and haplotypes by a novel haplotype-specific sequencing-based approach. The haplotypes 2/3 (padi4_89*G, padi4_90*T, padi4_92*G, padi4_94*T, padi4_104*T, padi4_95*C, padi4_96*C), and haplotype 4 (padi4_89*G, padi4_90*T, padi4_92*G, padi4_94*T, padi4_104*C, padi4_95*G, padi4_96*T) conferring susceptibility to rheumatoid arthritis were detected at frequencies of 30.9% and 7.8%, respectively. In addition, three novel coding SNPs in exons 2, 3, and 4, and three SNPs in introns 2 and 3 located near the exon-intron boundaries were identified in 11 individuals (10.8%). The so-called nonsusceptibility haplotype 1 (padi4_89*A, padi4_90*C, padi4_92*C, padi4_94*C, padi4_104*C, padi4_95*G, padi4_96*T) occurred at a frequency of 58.3%. Additionally, we identified a closely related novel haplotype, haplotype 1B (2.9%), that differs from haplotype 1 only by padi4_92*G/padi4_96*C. This haplotype was not described in the Japanese population. Our results indicate that the PADI4 gene exhibits a remarkable variability and a rather complex haplotypic organization. Further studies on disease association of PADI4 should be performed by haplotype-specific sequencing-based approaches to identify the exact genotype of the PADI4 fragment of interest.
PADI4 haplotypes in association with RA Mexican patients, a new prospect for antigen modulation.
Zavala-Cerna M, Gonzalez-Montoya N, Nava A, Gamez-Nava J, Moran-Moguel M, Rosales-Gomez R Clin Dev Immunol. 2014; 2013:383681.
PMID: 24454473 PMC: 3881379. DOI: 10.1155/2013/383681.
PADI2 is significantly associated with rheumatoid arthritis.
Chang X, Xia Y, Pan J, Meng Q, Zhao Y, Yan X PLoS One. 2013; 8(12):e81259.
PMID: 24339914 PMC: 3855321. DOI: 10.1371/journal.pone.0081259.
Levenstien M, Ott J, Gordon D PLoS Genet. 2006; 2(8):e127.
PMID: 16933998 PMC: 1550282. DOI: 10.1371/journal.pgen.0020127.
Hoppe B, Haupl T, Gruber R, Kiesewetter H, Burmester G, Salama A Arthritis Res Ther. 2006; 8(2):R34.
PMID: 16469113 PMC: 1526594. DOI: 10.1186/ar1889.
Cantaert T, Coucke P, De Rycke L, Veys E, de Keyser F, Baeten D Ann Rheum Dis. 2005; 64(9):1316-20.
PMID: 15760928 PMC: 1755666. DOI: 10.1136/ard.2004.033548.